Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice

Therapeutic options to control respiratory syncytial virus (RSV) are limited, thus development of new therapeutics is high priority. Previous studies with a monoclonal antibody (mAb) reactive to an epitope proximal to the central conserved region (CCR) of RSV G protein (mAb 131-2G) showed therapeuti...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Caidi, Hayat, Harcourt, Jennifer L., Tripp, Ralph A., Anderson, Larry J., Haynes, Lia M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2012
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3531420/
https://ncbi.nlm.nih.gov/pubmed/23300550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0051485
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk